Ravi V. Bellamkonda | |
---|---|
Born | 1968 (age 55–56) India |
Alma mater | |
Scientific career | |
Fields | Biomedical engineering, neural interfaces, human nervous system |
Institutions |
Ravi V. Bellamkonda (born 1968) is an Indian-American [1] biomedical engineer and academic administrator. Since 2021, he has served as Provost and Executive Vice President for Academic Affairs at Emory University in Atlanta, Georgia. [2] Bellamkonda was previously Vinik Dean of the Pratt School of Engineering at Duke University. [3]
Bellamkonda's laboratory explores the interplay of biomaterials and the nervous system for the development of peripheral nerve regeneration, brain electrode interfacing and brain tumor therapies. [4] His research was the subject of a BBC science report, "Cancer: 'Tumor Monorail' Can Lead Cancers to Their Doom" [5] He was also the subject of a feature profile in the Britain-based international journal, The Engineer . [6]
Bellamkonda served president of the American Institute of Medical and Biological Engineering (AIMBE) for the 2014-2016 term. [7] He has served as a member of the board for the Biomedical Engineering Society (BMES), and is on the editorial board for several scientific journals. He advises several biomedical engineering-related departments and programs nationally as a member of their external advisory boards.
Bellamkonda earned his Bachelor of Engineering degree in Biomedical Engineering at Osmania University in May 1989. He completed his Ph.D. in Medical Science and Biomaterials from Brown University in June 1994. [1] From 1994 to 1995, Bellamkonda was a Markey Post-Doctoral Research Fellow in the Department of Brain and Cognitive Sciences at the Massachusetts Institute of Technology with Jerry Schneider and Sonal Jhaveri.
In 1995, he went on to become the Elmer L. Lindseth assistant professor at Case Western Reserve University in Cleveland, Ohio then advanced to associate professor in 2001.
In 2003, Bellamkonda joined Georgia Tech as an associate professor of biomedical engineering, and in 2005, he was promoted to professor in the Wallace H. Coulter Department of Biomedical Engineering, a joint department created by Emory's School of Medicine and the Georgia Tech College of Engineering.
From 2006 to 2013, he was the Carol Ann and David D. Flanagan Chair in Biomedical Engineering at Georgia Tech. [8] the Carol Ann and David D. Flanagan Chair in Biomedical Engineering [9] and Georgia Cancer Coalition Distinguished Scholar [10]
In 2008, he was named deputy director of research at the Georgia Tech/Emory Center for the Engineering of Living Tissues (GTEC), an NSF funded engineering research center. [11] Afterwards, in 2010, he was named associate vice president for research at the Georgia Institute of Technology, a position he held until 2013. [11]
In 2013, Bellamkonda was named the department chair of the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University. [12] On August 1, 2016, he became Vinik Dean of the Pratt School of Engineering at Duke University. [13]
It was reported he will become Provost and Executive Vice President for Academic Affairs at Emory University on July 1, 2021, where he will have faculty appointments in the Department of Biology and the Wallace H. Coulter Department of Biomedical Engineering. [14]
Bellamkonda's primary area of research is the application of biomaterials to the human nervous system, including spinal nerve repair, neural interfaces, and brain tumor therapy. [15]
Biomedical engineering (BME) or medical engineering is the application of engineering principles and design concepts to medicine and biology for healthcare applications. BME is also traditionally logical sciences to advance health care treatment, including diagnosis, monitoring, and therapy. Also included under the scope of a biomedical engineer is the management of current medical equipment in hospitals while adhering to relevant industry standards. This involves procurement, routine testing, preventive maintenance, and making equipment recommendations, a role also known as a Biomedical Equipment Technician (BMET) or as a clinical engineer.
The Wallace H. Coulter Department of Biomedical Engineering is a department in the Emory University School of Medicine, Georgia Institute of Technology's College of Engineering, and Peking University College of Engineering dedicated to the study of and research in biomedical engineering, and is named after the pioneering engineer and Georgia Tech alumnus Wallace H. Coulter. The graduate program has consistently ranked 2nd in USNWR rankings, while the undergraduate program ranks 1st in USNWR rankings.
Dean Ho is a Provost's Chair Professor in the Departments of Biomedical Engineering and Pharmacology, Director of the N.1 Institute for Health, and Head of the Department of Biomedical Engineering at the National University of Singapore. He was previously a professor at UCLA, and associate professor in the Departments of Biomedical Engineering and Mechanical Engineering in the Robert R. McCormick School of Engineering and Applied Science, and Full Member of the Robert H. Lurie Comprehensive Cancer Center at the Feinberg School of Medicine of Northwestern University, Illinois, United States.
Nicholas (Nikolaos) A. Peppas is a chemical and biomedical engineer whose leadership in biomaterials science and engineering, drug delivery, bionanotechnology, pharmaceutical sciences, chemical and polymer engineering has provided seminal foundations based on the physics and mathematical theories of nanoscale, macromolecular processes and drug/protein transport and has led to numerous biomedical products or devices.
The American Institute for Medical and Biological Engineering (AIMBE) is a non-profit organization founded in 1991, and headquartered in Washington, D.C. It represents 50,000 medical and biomedical engineers, and academic institutions, private industry, and professional engineering societies.
Linda Gay Griffith is an American biological engineer, and Professor of Biological Engineering and Mechanical Engineering at Massachusetts Institute of Technology, where she also directs the Center for Gynepathology Research.
Stanislav (Stas) Emelianov is a former professor of biomedical engineering at University of Texas at Austin. He is also the founder of Ultrasound Imaging and Therapeutics Laboratory. Since August 2015, he moved to Georgia Institute of Technology, where he has been appointed as the Joseph M. Pettit Chair in Microelectronics and as a Georgia Research Alliance Eminent Scholar. He is based in the Georgia Tech School of Electrical and Computer Engineering with a joint appointment in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University.
George Alexander Truskey is an American biomedical engineer noted for his research on transport phenomena in biological systems, cardiovascular tissue engineering, and cell adhesion to natural and synthetic surfaces.
Rebecca Richards-Kortum is an American bioengineer and the Malcolm Gillis University Professor at Rice University. She is a professor in the departments of Bioengineering and Electrical and Computer Engineering, and she is the Director of Rice 360°: Institute for Global Health, and the Founder of Beyond Traditional Borders. She is the Director of the Institute of Biosciences and Bioengineering, and serves as the advisor to the Provost on health-related research.
Akhilesh K. Gaharwar is an Indian academic and a professor in the Department of Biomedical Engineering at Texas A&M University.
Omolola (Lola) Eniola-Adefeso is a Nigerian-American chemical engineer and the University Diversity and Social Transformation Professor of Chemical Engineering, Biomedical Engineering, and Macromolecular Science and Engineering at the University of Michigan. Eniola-Adefeso is also a co-founder and chief scientific officer of Asalyxa Bio. Her research looks to design biocompatible functional particles for targeted drug delivery.
Steven R. Little is an American chemical engineer and pharmaceutical scientist. He currently holds the title of department chair, distinguished professor, and the William Kepler Whiteford Endowed Professor of Chemical Engineering at the University of Pittsburgh Swanson School of Engineering. He also holds secondary appointments in bioengineering, pharmaceutical sciences, immunology, ophthalmology and the McGowan Institute for Regenerative Medicine at the University of Pittsburgh.
Eberhard O. Voit is a Clinical Professor at the University of Texas at Dallas. Until 2024, he was a Professor and David D. Flanagan Chair in Biological Systems at the Georgia Institute of Technology, where is now Professor Emeritus, and a Georgia Research Alliance Eminent Scholar. He leads the Laboratory for Biological Systems Analysis.
Guillermo Antonio Ameer is the Daniel Hale Williams Professor of biomedical engineering at the Robert R. McCormick School of Engineering and Applied Science and Surgery at the Feinberg School of Medicine of Northwestern University and is a fellow of the American Institute for Medical and Biological Engineering, Biomedical Engineering Society, American Institute of Chemical Engineers, American Association for the Advancement of Science, Materials Research Society, and American Academy of Arts and Sciences. He is an engineer, inventor, and entrepreneur.
Debra Auguste is an American chemical engineer and professor at Northeastern University in the department of chemical engineering. Auguste is dedicated to developing treatments for triple negative breast cancer, one of the most aggressive and fatal cancers that disproportionately affects African American women. Her lab characterizes biomarkers of triple negative breast cancer and develops novel biocompatible therapeutic technologies to target and destroy metastatic cancer cells. Auguste received the 2012 Presidential Early Career Award for Scientists and Engineers and in 2010 was named in the 50 Most Influential African-Americans in Technology. In 2020, Auguste became an Elected Fellow of the American Institute for Medical and Biological Engineering.
Manu Omar Platt is an American biomedical engineer serving as the director of the NIH Biomedical Engineering Technology Acceleration (BETA) center. He also serves as NIBIB Associate Director for Scientific Diversity, Equity and Inclusion.
Jennifer L. West is an American bioengineer. She is the current Dean of Engineering and Applied Science at the University of Virginia. She was the Fitzpatrick University Professor of Biomedical Engineering at Duke University from 2012-2021. In 2000, West cofounded Nanospectra Biosciences in Houston to develop a cancer therapy based on gold nanoparticles that destroy tumor cells and has been listed by MIT Technology Review as one of the 100 most innovative young scientists and engineers world wide.
Chenzhong Li is a Chinese-born Canadian & American biomedical engineer, chemist, inventor, professor, and journal editor. Li is the co-Editor-in-Chief of the journal Biosensors and Bioelectronics (Elsevier) and the associate editors of journals RESEARCH (AAAS) and Biosensors (MDPI).
Claudia Fischbach is a German bioengineer who is the Stanley Bryer 1946 Professor of Biomedical Engineering at Cornell University. She is Director of the Cornell Physical Sciences Oncology Center on the Physics of Cancer Metabolism.
May Dongmei Wang is a Chinese-American biomedical engineer whose research involves biomedical big data analytics, the interpretation and application of big data in medicine and biology, as generated from microarrays and quantum dots. She is a professor of biomedical engineering and Wallace H. Coulter Distinguished Faculty Fellow in the Wallace H. Coulter Department of Biomedical Engineering, a joint program of Georgia Tech, Emory University, and Peking University.